These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Targeting nicotine addiction: the possibility of a therapeutic vaccine. Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018 [TBL] [Abstract][Full Text] [Related]
23. [Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum]. Aparici M; Fernández González AL; Alegría E Rev Clin Esp; 1994 Jun; 194(6):453-6. PubMed ID: 8079014 [TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptor 5 as a potential target for smoking cessation. Chiamulera C; Marzo CM; Balfour DJK Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973 [TBL] [Abstract][Full Text] [Related]
25. Advances in pharmacotherapy for tobacco dependence. Foulds J; Burke M; Steinberg M; Williams JM; Ziedonis DM Expert Opin Emerg Drugs; 2004 May; 9(1):39-53. PubMed ID: 15155135 [TBL] [Abstract][Full Text] [Related]
26. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. Li X; Semenova S; D'Souza MS; Stoker AK; Markou A Neuropharmacology; 2014 Jan; 76 Pt B(0 0):554-65. PubMed ID: 23752091 [TBL] [Abstract][Full Text] [Related]
33. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Wing VC; Shoaib M Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868 [TBL] [Abstract][Full Text] [Related]
34. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056 [TBL] [Abstract][Full Text] [Related]
35. New mechanisms and perspectives in nicotine withdrawal. Jackson KJ; Muldoon PP; De Biasi M; Damaj MI Neuropharmacology; 2015 Sep; 96(Pt B):223-34. PubMed ID: 25433149 [TBL] [Abstract][Full Text] [Related]
36. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation. Escobar-Chávez JJ; Merino V; López-Cervantes M; Rodríguez-Cruz IM; Quintanar-Guerrero D; Ganem-Quintanar A Curr Drug Discov Technol; 2009 Sep; 6(3):171-85. PubMed ID: 19496753 [TBL] [Abstract][Full Text] [Related]
37. Nicotine and non-nicotine smoking cessation pharmacotherapies. Frishman WH; Mitta W; Kupersmith A; Ky T Cardiol Rev; 2006; 14(2):57-73. PubMed ID: 16493243 [TBL] [Abstract][Full Text] [Related]
38. Nicotine replacement therapy. Fant RV; Owen LL; Henningfield JE Prim Care; 1999 Sep; 26(3):633-52. PubMed ID: 10436291 [TBL] [Abstract][Full Text] [Related]
39. [Drug aid to tobacco withdrawal]. Bobrie G; Battaglia C; Loufrani E; Ménard J Rev Prat; 1993 May; 43(10):1238-44. PubMed ID: 8235362 [TBL] [Abstract][Full Text] [Related]
40. Emerging drugs for the treatment of tobacco dependence. Ebbert JO Expert Opin Emerg Drugs; 2009 Mar; 14(1):23-32. PubMed ID: 19278367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]